Guggenheim Maintains Buy on Eli Lilly, Lowers Price Target to $1163

Benzinga Newsdesk www.benzinga.com Negative 73.8%

Neg 73.8% Neu 0% Pos 0%

Guggenheim analyst Seamus Fernandez maintains Eli Lilly (NYSE:LLY) with a Buy and lowers the price target from $1168 to $1163.